1,673 results on '"Herzyk, Danuta"'
Search Results
2. Re-evaluating the need for chronic toxicity studies with therapeutic monoclonal antibodies, using a weight of evidence approach
3. Industry experiences with immune-mediated findings in biotherapeutic nonclinical toxicology studies
4. Nonclinical safety of tildrakizumab, a humanized anti–IL-23p19 monoclonal antibody, in nonhuman primates
5. Drug safety Africa: An overview of safety pharmacology & toxicology in South Africa
6. Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis.
7. Immunoassays
8. Supplementary Figures S1 through S10 from Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells
9. Supplementary Tables S1 and S2 from Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells
10. Data from Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells
11. Supplementary Methods from Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells
12. FDA and industry collaboration: Identifying opportunities to further reduce reliance on nonhuman primates for nonclinical safety evaluations
13. Strategies for the Nonclinical Safety Assessment of Vaccines
14. Immunoassays
15. Cancer Immunotherapy: Factors Important for the Evaluation of Safety in Nonclinical Studies
16. Immunoassays
17. Immunogenicity of biologically-derived therapeutics: Assessment and interpretation of nonclinical safety studies
18. The Pharmacokinetics, Antigenicity, and Fusion-Inhibition Activity of RSHZ19, a Humanized Monoclonal Antibody to Respiratory Syncytial Virus, in Healthy Volunteers
19. Overview of Biosimilar Therapeutics
20. Contributors
21. Strategies for the Nonclinical Safety Assessment of Vaccines
22. The T-Dependent Antibody Response to Keyhole Limpet Hemocyanin in Rodents
23. Approaches to Evaluation of Autoimmunity
24. Biophysical and Immunological Characterization and In Vivo Pharmacokinetics and Toxicology in Nonhuman Primates of the Anti-PD-1 Antibody Pembrolizumab
25. Relationships between antibodies against human soluble complement receptor 1 (hsCR1) from various species
26. Assessing immunotoxicity of pharmaceuticals: the need for enhanced testing
27. Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation
28. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys
29. Identification of natural antibodies to interleukin-18 in the sera of normal humans and three nonhuman primate species
30. A T-cell-dependent antibody response study using a murine surrogate anti-PD-1 monoclonal antibody as an alternative to a non-human primate model
31. Flow Cytometry in the Preclinical Development of Biopharmaceuticals
32. IMMUNOPHARMACOLOGY OF RECOMBINANT HUMAN INTERLEUKIN-18 IN NON-HUMAN PRIMATES
33. ELISA Detection of IL-Iβ in Human Sera Needs Independent Confirmation: False Positives in Hospitalized Patients
34. Atiprimod (SKandF 106615), a novel macrophage targeting agent, enhances alveolar macrophage candidacidal activity and is not immunosuppresive in candida-infected mice
35. Characterization of MK-4166, a Clinical Agonistic Antibody That Targets Human GITR and Inhibits the Generation and Suppressive Effects of T Regulatory Cells
36. An Evaluation of the Impact of PD‐1 Pathway Blockade on Reproductive Safety of Therapeutic PD‐1 Inhibitors
37. Chapter 5 - Overview of Biosimilar Therapeutics
38. Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics
39. Vaccines Europe reflection paper on the safety assessment of residuals and contaminants in vaccines
40. Comparison of immune function tests using T-cell dependent antigens: A meta-analysis
41. Summary of a workshop on nonclinical and clinical immunotoxicity assessment of immunomodulatory drugs
42. Immunotoxicity Evaluation by Immune Function Tests: Focus on the T-Dependent Antibody Response (TDAR) [Overview of a Workshop Session at the 45th Annual Meeting of the Society of Toxicology (SOT) March 5–9, 2006 San Diego, CA]
43. Preclinical Safety of Recombinant Human Interleukin-18
44. The T-Dependent Antibody Response to Keyhole Limpet Hemocyanin in Rodents.
45. Antidrug Antibody Responses in Nonclinical Studies and their Implications.
46. Developmental Immunotoxicity in Rodents.
47. Systemic Hypersensitivity.
48. Bridging Immunotoxicology to Clinical Drug Development.
49. T Cell-Dependent Antibody Response Tests.
50. Relevant Immune Tests across Different Species and Surrogate Models.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.